25 May 2013
Keywords: Eli Lilly, Alimta, UK, NICE, NSCLC maintenance
Article | 22 February 2013
UK drugs watchdog the National Institute for Health and Clinical Excellence (NICE) has issued new draft guidance not recommending US ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 February 2013
24 May 2013
© 2013 thepharmaletter.com